Retro
Developer of therapeutics designed to extend healthy human lifespan by targeting the biological mechanisms of aging. The company offers a platform that integrates single-cell multi-omics, pooled pertu...
Valuation
$0
Share Price
N/A
Total Raised
$1.2B
Last Round
N/A